Intellispace Cardiovascular
CVE-2018-5438
MEDIUM
Vulnerability Assessment
| Weakness |
CWE
OWASP Top 10:2025
A07:2025 - Authentication Failures
ASVS 5.0
V7 - Session Management Session expiration enforcement
|
| Impact | CVSS score of 6.3 (MEDIUM). Attack characteristics: local attack vector, high complexity, low privileges required, no user interaction not required. |
| Exploit ScenarioDerived | Successful exploitation could compromise the medium-severity affected system. |
Get an e-mail when this CVE is exploited, patched or re-scored. Free account.
Alert meAnalysisAI
Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker could reuse the session of a previously logged in user. Rated medium severity (CVSS 6.3). No vendor patch available.
RemediationAI
No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.
Affects your stack
Find out whether the stacks and servers you run are on an affected version.
Checking this CVE against your own stacks and servers is part of the Basic plan and up.
Technical ContextAI · show details
This vulnerability is classified under CWE-613. Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker could reuse the session of a previously logged in user. This vulnerability exists when using ISCV together with an Electronic Medical Record (EMR) system, where ISCV is in KIOSK mode for multiple users and using Windows authentication. This may allow an attacker to gain unauthorized access to patient health information and potentially modify this information. Affected products include: Philips Intellispace Cardiovascular. Version information: version 2.3.0.
Know when Intellispace Cardiovascular gets its next vulnerability
- Watch products and get an email when something new is published
- Check this CVE against your own stack and servers
- Exploit and PoC references, threat intelligence from 22 sources
No credit card · 7-day full trial
Severity by source
AV:L/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:N
Primary rating from NVD · only source for this CVE.
CVSS VectorNVD
DescriptionNVD
Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker could reuse the session of a previously logged in user. This vulnerability exists when using ISCV together with an Electronic Medical Record (EMR) system, where ISCV is in KIOSK mode for multiple users and using Windows authentication. This may allow an attacker to gain unauthorized access to patient health information and potentially modify this information.
Threat Intelligence Overview
How this decision was reached
The engine reads each signal below and applies a fixed list of rules from top to bottom. The first rule that matches sets the recommended action – like a statement, every line is shown.
What every action level means
SSVC AssessmentENISA
Priority Score
Attack Technique
Authentication bypass attacks exploit flaws in the verification mechanisms that control access to systems and applications.
Affected Products (CPE)NVD
More in Intellispace Cardiovascular
View allIn Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an
The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an
NVD
CVE.org
EPSS
GitHub PoC
Exploit-DB